
Sign up to save your podcasts
Or


Brent Lavin, Director of Strategic Growth at BD, joins the show to break down the art and science of medtech M&A. Discover the three key characteristics that determine whether a company builds new tech organically or acquires it and why most get it wrong. He shares real-world stories from acquisitions like Straub Medical and Close, including surprises that only show up after the deal is done. Plus: why startups must now plan for global regulatory hurdles from day one, how to use data for hyper-targeted commercial launches, and the leadership books that shaped his career. Essential listening for anyone in business development, product management, or startup leadership.
Press play to learn more.
Episode Breakdown
00:00 - Intro: Companies Who Nail Acquisitions & Strategy
01:20 - Meet Brent Lavin: Director of Strategic Growth at BD
03:55 - Brent Lavin’s Path from Engineering to MedTech
07:40 - How an ER Visit Sparked His MedTech Career
10:20 - GE Healthcare & Early Commercial Experience
12:15 - Moving to Bard/BD & 20 Years in Innovation
14:05 - Build vs. Buy: How Strategics Decide
17:10 - What Brent Lavin Oversees at BD (Vascular & ESKD)
18:45 - How BD Evaluates Acquisition Targets
21:30 - Examples of Successful Acquisitions in MedTech
23:50 - Lessons from Integrating Acquired Technologies
26:18 - Surprises Found After Closing Deals
28:12 - Institutional Knowledge vs. AI Tools
29:25 - How Real Innovation Ideas Are Found
31:10 - Observing Procedures vs. What Physicians SAY They Need
33:12 - Post-Market Feedback & Iteration
34:55 - Companies Brent Lavin Respects for Strategy (Intuitive, Edwards)
36:42 - Who Still Builds Good Innovation In-House?
38:25 - Why M&A Is Heating Back Up in MedTech
40:10 - Commercial Systems That Make a Startup “Acquirable”
42:05 - Regulatory Reality: MDR, Global Scale & Readiness
44:00 - Signals BD Watches to Spot Early Winners
45:18 - How Venclose Came Onto BD’s Radar (Case Study)
47:05 - Red Flags That Kill an Acquisition
48:00 - Brent Lavin’s Favorite Leadership Books & Daily Tech Stack
48:40 - Closing Thoughts & How to Connect with Brent Lavin
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#MedTech #MedicalDevices #HealthcareInnovation #BusinessDevelopment #MedicalTechnology
By State of MedtechBrent Lavin, Director of Strategic Growth at BD, joins the show to break down the art and science of medtech M&A. Discover the three key characteristics that determine whether a company builds new tech organically or acquires it and why most get it wrong. He shares real-world stories from acquisitions like Straub Medical and Close, including surprises that only show up after the deal is done. Plus: why startups must now plan for global regulatory hurdles from day one, how to use data for hyper-targeted commercial launches, and the leadership books that shaped his career. Essential listening for anyone in business development, product management, or startup leadership.
Press play to learn more.
Episode Breakdown
00:00 - Intro: Companies Who Nail Acquisitions & Strategy
01:20 - Meet Brent Lavin: Director of Strategic Growth at BD
03:55 - Brent Lavin’s Path from Engineering to MedTech
07:40 - How an ER Visit Sparked His MedTech Career
10:20 - GE Healthcare & Early Commercial Experience
12:15 - Moving to Bard/BD & 20 Years in Innovation
14:05 - Build vs. Buy: How Strategics Decide
17:10 - What Brent Lavin Oversees at BD (Vascular & ESKD)
18:45 - How BD Evaluates Acquisition Targets
21:30 - Examples of Successful Acquisitions in MedTech
23:50 - Lessons from Integrating Acquired Technologies
26:18 - Surprises Found After Closing Deals
28:12 - Institutional Knowledge vs. AI Tools
29:25 - How Real Innovation Ideas Are Found
31:10 - Observing Procedures vs. What Physicians SAY They Need
33:12 - Post-Market Feedback & Iteration
34:55 - Companies Brent Lavin Respects for Strategy (Intuitive, Edwards)
36:42 - Who Still Builds Good Innovation In-House?
38:25 - Why M&A Is Heating Back Up in MedTech
40:10 - Commercial Systems That Make a Startup “Acquirable”
42:05 - Regulatory Reality: MDR, Global Scale & Readiness
44:00 - Signals BD Watches to Spot Early Winners
45:18 - How Venclose Came Onto BD’s Radar (Case Study)
47:05 - Red Flags That Kill an Acquisition
48:00 - Brent Lavin’s Favorite Leadership Books & Daily Tech Stack
48:40 - Closing Thoughts & How to Connect with Brent Lavin
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#MedTech #MedicalDevices #HealthcareInnovation #BusinessDevelopment #MedicalTechnology